Showing results (1641-1650 of 1,677) with videos related to

Sort By:
Pageof 168
Ebiomedicine|May 7, 2023
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialTian-Tian Li, Bo Zhang, Hui Fang, et al.
Ebiomedicine|June 29, 2026
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infectionYou-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, et al.
Stem Cell Research & Therapy|February 26, 2025
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trialMeng-Qi Yuan, Le Song, Ze-Rui Wang, et al.
Nature Metabolism|June 23, 2021
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Nature Ecology & Evolution|January 18, 2024
Initial Upper Palaeolithic material culture by 45,000 years ago at Shiyu in northern ChinaShi-Xia Yang, Jia-Fu Zhang, Jian-Ping Yue, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2024
Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysisBing Zhuang, Liangying Gan, Bin Liu, et al.
Hepatology International|September 15, 2022
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureHua-Jie Li, Ning Yang, Xiuying Mu, et al.
Biomedical and Environmental Sciences : BES|July 8, 2026
Association between Urinary Cobalt and All-cause and Cause-specific Mortality among Chinese Older Adults: A Prospective Cohort StudyYu Dong Wu, Yong Qiang Chen, Chen Chen, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Hepatology (Baltimore, Md.)|January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progressionJia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Pageof 168